microarray pins capitalbio smartarrayer 136 (CapitalBio Corporation)
90
Structured Review
CapitalBio Corporation
microarray pins capitalbio smartarrayer 136
Microarray Pins Capitalbio Smartarrayer 136, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+pins+capitalbio+smartarrayer+136/contact+printer+capitalbio+smartarrayer+136/pmc08775591-340-6-5
Average 90 stars, based on 1 article reviews
Microarray Pins Capitalbio Smartarrayer 136, supplied by CapitalBio Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microarray+pins+capitalbio+smartarrayer+136/contact+printer+capitalbio+smartarrayer+136/pmc08775591-340-6-5
Average 90 stars, based on 1 article reviews
microarray pins capitalbio smartarrayer 136 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
Blocking Assay:Article Title: Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis Article Snippet: .. Each sample was printed three times in each block (9 × 10 format) and 14 identical blocks per slide using a Article Title: Antibody Profiling in COVID-19 Patients with Different Severities by Using Spike Variant Protein Microarrays Article Snippet: .. Each block on the slides was printed with 23 variant viral proteins including alpha/beta/gamma mutant type coronavirus, 5 cell lysates, and 8 control mix with 30% glycerol ( Table S1 ) in technical triplicates to generate 9 × 12 formats by using a Article Title: Development and Application of Human Coronavirus Protein Microarray for Specificity Analysis Article Snippet: .. 2021, 93, 7690−7698 7691 times in each block (9 × 10 format) and 14 identical blocks per slide using a Variant Assay:Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays. Article Snippet: In Brief Owing to the ongoing mutations of SARS-CoV-2, we developed an up-to-date CoVariant protein microarray to profile the humoral immunity.. We collected plasmas from healthy subjects who underwent two doses of matching (AZD1222 ×2 or mRNA-1273 ×2) and two doses of mixing (AZD1222 + mRNA1273).. We found that mixing generates more surrogate neutralizing activity against gamma and omicron than matching. Article Title: Antibody Profiling in COVID-19 Patients with Different Severities by Using Spike Variant Protein Microarrays Article Snippet: .. Each block on the slides was printed with 23 variant viral proteins including alpha/beta/gamma mutant type coronavirus, 5 cell lysates, and 8 control mix with 30% glycerol ( Table S1 ) in technical triplicates to generate 9 × 12 formats by using a Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays Article Snippet: .. A Control:Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays. Article Snippet: In Brief Owing to the ongoing mutations of SARS-CoV-2, we developed an up-to-date CoVariant protein microarray to profile the humoral immunity.. We collected plasmas from healthy subjects who underwent two doses of matching (AZD1222 ×2 or mRNA-1273 ×2) and two doses of mixing (AZD1222 + mRNA1273).. We found that mixing generates more surrogate neutralizing activity against gamma and omicron than matching. Article Title: Antibody Profiling in COVID-19 Patients with Different Severities by Using Spike Variant Protein Microarrays Article Snippet: .. Each block on the slides was printed with 23 variant viral proteins including alpha/beta/gamma mutant type coronavirus, 5 cell lysates, and 8 control mix with 30% glycerol ( Table S1 ) in technical triplicates to generate 9 × 12 formats by using a Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays Article Snippet: .. A Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. Membrane:Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays. Article Snippet: In Brief Owing to the ongoing mutations of SARS-CoV-2, we developed an up-to-date CoVariant protein microarray to profile the humoral immunity.. We collected plasmas from healthy subjects who underwent two doses of matching (AZD1222 ×2 or mRNA-1273 ×2) and two doses of mixing (AZD1222 + mRNA1273).. We found that mixing generates more surrogate neutralizing activity against gamma and omicron than matching. Article Title: Profiling Humoral Immunity After Mixing and Matching COVID-19 Vaccines Using SARS-CoV-2 Variant Protein Microarrays Article Snippet: .. A Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. Mutagenesis:Article Title: Antibody Profiling in COVID-19 Patients with Different Severities by Using Spike Variant Protein Microarrays Article Snippet: .. Each block on the slides was printed with 23 variant viral proteins including alpha/beta/gamma mutant type coronavirus, 5 cell lysates, and 8 control mix with 30% glycerol ( Table S1 ) in technical triplicates to generate 9 × 12 formats by using a Negative Control:Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. Positive Control:Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. Saline:Article Title: Profiling humoral responses to COVID-19 immunization in Kawasaki disease using SARS-CoV-2 variant protein microarrays. Article Snippet: Kawasaki disease (KD) is a form of acute systemic vasculitis syndrome that predominantly occurs in children under the age of 5 years.. Its etiology has been postulated due to not only genetic factors but also the presence of foreign antigens or infectious agents.. To evaluate possible associations between Kawasaki disease (KD) and COVID-19, we investigated humoral responses of KD patients against S-protein variants with SARS-CoV-2 variant protein microarrays. Microarray:Article Title: Systematic Screening of Penetratin’s Protein Targets by Yeast Proteome Microarrays Article Snippet: .. Using 48 |